Search

A polymyxin B (PMB) modified copolymer of ethyl acrylate and 2-hydroxyethyl methacrylate is reported that shows antibacterial activity towards E. coli. The polymer is designed for biosensor interfaces to provide protection against microbial contamination. However, leaching of a biomolecule from its solid support is a well-known problem in immobilization chemistry. It has been proposed that antimicrobial activity results from release of the antibiotic from the polymer matrix, but in the work reported here, bactericidal action was seen for tresyl activated polymers even when no polymyxin B could be detected in the supernatant and where covalent attachment of PMB was indicated. Further evidence for the in situ action of PMB on the polymer was provided using a novel method of investigation, subjecting the polymer, deposited on an Ion-Sensitive Field-Effect Transistor (ISFET) to a step change in ion-concentration (Ion-step). With the ion-step method activation of the polymer and the grafting of Polymyxin-B were followed. A comparison of absorbed PMB on a nonactivated polymer and PMB on the tresyl activated polymer suggested that if leaching of PMB from the latter occurred, it was below the detection limit and well below the minimum inhibitory concentration (MIC) for antimicrobial action. Bactericidal action was thus attributed to PMB attached to the polymer. [ABSTRACT FROM AUTHOR]

Bacillus stearothermophilus large fragment (BSTLF) DNA polymerase is reported, isolated on silica via a fused R5 silica-affinity peptide and used in nucleic acid diagnostics. mCherry (mCh), included in the fusion construct, was shown as an efficient fluorescent label to follow the workflow from gene to diagnostic. The R5 immobilisation on silica from cell lysate was consistent with cooperative R5-specific binding of R52-mCh-FL-BSTLF or R52-mCh-H10-BSTLF fusion proteins followed by non-specific protein binding (including E. coli native proteins). Higher R5-binding could be achieved in the presence of phosphate, but phosphate residue reduced loop-mediated isothermal amplification (LAMP) performance, possibly blocking sites on the BSTLF for binding of β- and γ-phosphates of the dNTPs. Quantitative assessment showed that cations (Mg2+ and Mn2+) that complex the PPi product optimised enzyme activity. In malaria testing, the limit of detection depended on Plasmodium species and primer set. For example, 1000 copies of P. knowlesi 18S rRNA could be detected with the P.KNO-LAU primer set with Si-R52-mCh-FL-BSTLF , but 10 copies of P. ovale 18S rRNA could be detected with the P.OVA-HAN primer set using the same enzyme. The Si-immobilised BSTLF outperformed the commercial enzyme for four of the nine Plasmodium LAMP primer sets tested. Si-R52-mCh-FL-BSTLF production was transferred from Cambridge to Accra and set up de novo for a trial with clinical samples. Different detection limits were found, targeting the mitochondrial DNA or the 18S rRNA gene for P. falciparum. The results are discussed in comparison with qPCR and sampling protocol and show that the Si-BSTLF polymerase can be optimised to meet the WHO recommended guidelines. [ABSTRACT FROM AUTHOR]